MESO insider buying and SEC filings, explained
Mesoblast Ltd. · CIK 1345099
Tracked: Forms 3/4/5, 8-K, NT · Limited coverage: files 6-K/20-F, not covered in v1 · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq, OTC
- Industry (SIC)
- Biological Products, (No Diagnostic Substances)
- State of incorporation
- C3
- Fiscal year end
- Jun 30
Insider activity in the last 12 months
Bought
$37.5M
Insiders who bought
1
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Apr 4–10, 2026 | Purchase (code P) | Gregory George (Director and 10% owner) bought 7,910,962 shares indirectly between Apr 4 and Apr 10 at about $1.44 ($11.4M), reported as a purchase (code P). Indirect holdings up 50% to 12,000,000 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Apr 13, 2026 |
| Apr 4–10, 2026 | Purchase (code P) | Gregory George (Director and 10% owner) bought 8,305,962 shares indirectly between Apr 4 and Apr 10 at about $3.15 ($26.1M), reported as a purchase (code P). Indirect holdings up 50% to 12,000,000 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Apr 10, 2026 |
1 routine transaction (such as a grant, option exercise or tax withholding) is not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow MESO in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.